36 related articles for article (PubMed ID: 34319166)
1. Glioblastoma immunotherapy: time for hope?
Sferruzza G; Finocchiaro G
Neurol Sci; 2024 Jan; 45(1):357-358. PubMed ID: 37700174
[No Abstract] [Full Text] [Related]
2. Reply to Editorial Comment on "Effect of USMLE Score Cutoffs on Recruitment of Underrepresented Applicants in the Urology Match".
Kaldany A; Leitner DV; Jang TL
Urology; 2024 May; 187():32. PubMed ID: 38428750
[No Abstract] [Full Text] [Related]
3. FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease.
Høilund-Carlsen PF; Revheim ME; Alavi A; Barrio JR
Clin Nucl Med; 2023 Aug; 48(8):689-691. PubMed ID: 37314733
[TBL] [Abstract][Full Text] [Related]
4. Limbic encephalitis.
Bien CG
Handb Clin Neurol; 2022; 187():467-487. PubMed ID: 35964988
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
6. Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Galldiks N; Langen KJ; Holy R; Pinkawa M; Stoffels G; Nolte KW; Kaiser HJ; Filss CP; Fink GR; Coenen HH; Eble MJ; Piroth MD
J Nucl Med; 2012 Jul; 53(7):1048-57. PubMed ID: 22645298
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
Piroth MD; Pinkawa M; Holy R; Klotz J; Nussen S; Stoffels G; Coenen HH; Kaiser HJ; Langen KJ; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):176-84. PubMed ID: 20646863
[TBL] [Abstract][Full Text] [Related]
8. Editorial Comment: MRI and PET for Immunotherapy Response Assessment in Glioblastoma Multiforme.
Prattipati V
AJR Am J Roentgenol; 2022 Apr; 218(4):597. PubMed ID: 34319166
[No Abstract] [Full Text] [Related]
9. State of the Art Treatment and Surveillance Imaging of Glioblastomas.
Margiewicz S; Cordova C; Chi AS; Jain R
Semin Roentgenol; 2018 Jan; 53(1):23-36. PubMed ID: 29405952
[No Abstract] [Full Text] [Related]
10. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma.
Li Y; Ma Y; Wu Z; Xie R; Zeng F; Cai H; Lui S; Song B; Chen L; Wu M
Front Immunol; 2021; 12():790674. PubMed ID: 34899760
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
